Evidence map›Paper›PMID 30115078›Full record

ArticleJournal of experimental & clinical cancer research : CR2018

KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.

Jie Li, Qian Liu, Zihao Liu, Qian Xia, Zihao Zhang, Rui Zhang, Taihong Gao, Guangyan Gu, Yanan Wang, Dan Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Jie LiDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China.
Qian LiuDepartment of Histology and Embryology, Shandong University Cheeloo College of Medicine, Jinan, 250012, Shandong, China.
Zihao LiuJiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
Qian XiaJiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
Zihao ZhangJiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
Rui ZhangDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China.
Taihong GaoDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China.
Guangyan GuDepartment of Histology and Embryology, Shandong University Cheeloo College of Medicine, Jinan, 250012, Shandong, China.
Yanan WangDepartment of Histology and Embryology, Shandong University Cheeloo College of Medicine, Jinan, 250012, Shandong, China.
Dan WangDepartment of Histology and Embryology, Shandong University Cheeloo College of Medicine, Jinan, 250012, Shandong, China.
Xiuyang ChenDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China.
Yihang YangDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China.
Dong HeDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China.
Tao XinDepartment of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China. drxintao@yeah.net.
Shandong University · CNNanchang University · CNShandong Provincial Hospital · CNFirst Affiliated Hospital of Jiangxi Medical College · CNJiangxi Provincial People's Hospital · CN

Funding

Early Detection of Pancreatic CancerR21CA118164 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI HAUN, RANDY S · 2006 to 2007
$290k
Distinguished Middle-Aged and Young Scientist Encourage and Reward Foundation of Shandong Province Grant No. ZR2014HP054Distinguished Middle-Aged and Young Scientist Encourage and Reward Foundation of Shandong Province ZR2014HQ015Jinan Science and Technology Bureau (CN) 201602162Ministerio de Ciencia y Tecnología, Gobierno de la Provincia de Córdoba (AR) 2015GSF118164National Natural Science Foundation of China 81471517Natural Science Foundation of Shandong Province ZR2014HM010Natural Science Foundation of Shandong Province ZR2016HM59
6 · The paper itself

Abstract

backgroundCancer cells maintain energy metabolism mainly by glycolysis, even under sufficient oxygen conditions. It gives cancer cells better growth advantages under complicated internal environment. KPNA2 is a novel oncogene that has received much attention in recent years, but the exact mechanisms of KPNA2 in tumorigenesis and progression are largely unknown. Especially its potential roles in the metabolic transformation of tumors still remain to be explored.

methodsThe expressions of KPNA2 in glioblastoma and normal human brain samples were analyzed by immunohistochemical analysis. The activities of key enzymes in glycolysis, the production of lactate acid and glucose uptake were investigated by colorimetry. GLUT-1 expression was measured by flow cytometry. CCK8 was used to examine the cell viability in vitro, and the xenograft models in nude mice were established to explore the roles of KPNA2 in vivo. In addition, Co-IP, subcellular fractionation, western blot, immunofluorescence and luciferase assay were used to investigate the internal connection between KPNA2, c-myc and E2F1.

resultsIn the present study, we found that KPNA2 was highly expressed in the glioma compared to the normal brain tissues. Level of KPNA2 was an independent predictor of prognosis in the glioma patients. Knockdown of KPNA2 in the glioblastoma cell lines U87 and U251 decreased deoxyglucose uptake, activities of the key glycolytic enzymes and lactate production. The level of oxidative phosphorylation (OXPHOS) was moderately decreased. Additioanlly, tumor proliferation and invasiveness were concomitantly downregulated. We have identified c-myc as a potential mediator of KPNA2. Aberrant expression of KPNA2 significantly changed the subcellular distribution of c-myc as well as its expression level. E2F1, another key cargo protein of KPNA2, was further identified to play a potential role in regulating the transcription of c-myc by KPNA2.

conclusionsOur findings suggested that KPNA2, a potential tumor oncogene, performs its function in part via regulating cellular metabolism through c-myc signaling axis. It would provide a possible explanation for Warburg effect and thus offer a new perspective to the roles of KPNA2 in gliomagenesis.

Indexed as

alpha KaryopherinsAnimalsBrain NeoplasmsCase-Control StudiesCell Line, TumorGlioblastomaHeterograftsHumansMaleMiceMice, NudeOxidative PhosphorylationProto-Oncogene Proteins c-mycSignal TransductionTransfectionalpha KaryopherinsKPNA2 protein, humanMYC protein, humanProto-Oncogene Proteins c-mycc-mycE2F1GliomaKPNA2Warburg effect

Identifiers

PMID30115078
PMCPMC6097452
OpenAlexW2887945559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.